Smart Money Is Betting Big In MRNA Options
Smart Money Is Betting Big In MRNA Options
Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 13 unusual trades.
金融巨头在Moderna上做空了，我们分析了Moderna(NASDAQ:MRNA)的期权历史，发现了13笔异常交易。
Delving into the details, we found 7% of traders were bullish, while 76% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $385,463, and 8 were calls, valued at $299,598.
具体来看，我们发现7%的交易者看多，而76%的交易者看空。在所有我们发现的交易中，有5笔为看跌期权，总价值383,463美元，有8笔为看涨期权，总价值299,598美元。
Expected Price Movements
预期价格波动
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $65.0 and $200.0 for Moderna, spanning the last three months.
经过对成交量和未平仓合约的评估，很明显主要的市场动向集中在65.0美元至200.0美元之间的价格区间内，涵盖了过去三个月。
Insights into Volume & Open Interest
成交量和持仓量分析
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 822.27 with a total volume of 1,051.00.
就流动性和利益而言，今天Moderna期权交易的平均未平仓合约为822.27，总成交量为1,051.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $65.0 to $200.0 over the last 30 days.
在下面的图表中，我们可以追踪过去30天内Moderna大额交易看跌和看涨期权的成交量和未平仓合约的发展情况，在65.0美元至200.0美元的行权价格范围内。
Moderna Option Activity Analysis: Last 30 Days
Moderna期权活动分析：过去30天
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | SWEEP | BEARISH | 11/15/24 | $11.15 | $11.1 | $11.1 | $85.00 | $152.1K | 237 | 139 |
| MRNA | PUT | TRADE | BULLISH | 01/17/25 | $58.6 | $58.2 | $58.2 | $140.00 | $110.5K | 899 | 30 |
| MRNA | CALL | TRADE | BEARISH | 06/20/25 | $9.45 | $9.2 | $9.2 | $110.00 | $61.6K | 220 | 67 |
| MRNA | PUT | SWEEP | BEARISH | 09/20/24 | $10.35 | $10.0 | $10.35 | $90.00 | $53.8K | 2.4K | 52 |
| MRNA | CALL | TRADE | BEARISH | 12/18/26 | $18.15 | $15.4 | $15.4 | $130.00 | $46.2K | 353 | 30 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Moderna | 看跌 | SWEEP | 看淡 | 11/15/24 | $11.15 | 11.1美元 | 11.1美元 | $85.00 | $152.1K | 237 | 139 |
| Moderna | 看跌 | 交易 | 看好 | 01/17/25 | 58.6美元 | $58.2 | $58.2 | $140.00 | 110.5K | 899 | 30 |
| Moderna | 看涨 | 交易 | 看淡 | 06/20/25 | 9.45 | $9.2 | $9.2 | $110.00 | $61.6K | 220 | 67 |
| Moderna | 看跌 | SWEEP | 看淡 | 09/20/24 | $10.35 | $10.0 | $10.35 | $90.00 | $53.8K | 2.4K | 52 |
| Moderna | 看涨 | 交易 | 看淡 | 12/18/26 | $18.15 | $15.4 | $15.4 | $130.00 | $46.2千 | 353 | 30 |
About Moderna
关于现代
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Moderna是一家成立于2010年并于2018年12月进行首次公开发行的商业化生物技术公司。该公司的mRNA技术得到了验证，其COVID-19疫苗在2020年12月获得美国授权。截至2023年中期，Moderna共有39个mRNA开发候选药物处于临床试验中。这些项目涉及多个治疗领域，包括传染病、肿瘤、心血管疾病和罕见遗传疾病。
Having examined the options trading patterns of Moderna, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在研究了Moderna的期权交易模式之后，我们现在将注意力直接转向该公司。这个转变使我们能够深入了解它的现在市场地位和表现。
Moderna's Current Market Status
Moderna的当前市场地位
- With a trading volume of 996,645, the price of MRNA is up by 0.59%, reaching $81.77.
- Current RSI values indicate that the stock is may be oversold.
- Next earnings report is scheduled for 79 days from now.
- MRNA的交易量为996,645美元，价格上涨了0.59%，达到81.77美元。
- 当前RSI指标表明该股可能被超卖。
- 下一份财务报告将于79天后公布。
Professional Analyst Ratings for Moderna
Moderna的专业分析师评级
In the last month, 5 experts released ratings on this stock with an average target price of $126.0.
在过去的一个月中，有5位专家发布了对该股票的评级，平均目标价为126.0美元。
- An analyst from RBC Capital downgraded its action to Sector Perform with a price target of $90.
- An analyst from Piper Sandler downgraded its action to Overweight with a price target of $157.
- An analyst from RBC Capital persists with their Outperform rating on Moderna, maintaining a target price of $125.
- Consistent in their evaluation, an analyst from Goldman Sachs keeps a Buy rating on Moderna with a target price of $178.
- Showing optimism, an analyst from Deutsche Bank upgrades its rating to Hold with a revised price target of $80.
- RBC Capital的分析师将其行动下调至板块持有，目标价为90美元。
- Piper Sandler的分析师将其行动下调至看涨，目标价为157美元。
- RBC Capital的分析师仍然坚持对Moderna的跑赢大盘评级，目标价为125美元。
- 高盛(Goldman Sachs)分析师一致对Moderna给予买入评级，目标价为178美元。
- 德意志银行(Deutsche Bank)的分析师看好，将评级升级为持有，目标价修订为80美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
期权交易存在更高的风险和潜在的回报。精明的交易者通过不断自我教育，调整策略，监控多个因子并密切关注市场动向来管理这些风险。通过Benzinga Pro获得有关最新Moderna期权交易的实时警报，以保持及时了解。